PENTAMIDINE ISETHIONATE | N019264 | FRESENIUS KABI USA LLC
| Trial | Phase | Status | Sponsor | Enrollment | Dates |
|---|---|---|---|---|---|
| Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 364 | — → 1991-09 | |
| N/A | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | — → 1992-01 | |
| N/A | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | — → 1991-06 | |
| N/A | Completed | Fisons | — | — | |
| Phase 3 | Completed | Glaxo Wellcome | 615 | — | |
| N/A | Completed | LyphoMed | — | — | |
| Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 400 | — → 1994-06 | |
| Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 322 | — → 1991-08 | |
| N/A | Completed | LyphoMed | — | — | |
| N/A | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | — → 1991-06 |
Source: ClinicalTrials.gov. Trials matched by ingredient name.
Lowest Price
$492.72
Highest Price
$1643.64
FSS NDCs
1
Big4 NDCs
1
| Description | Price | Type | Vendor | Contract End |
|---|---|---|---|---|
| 63323-0113-10PENTAM 300 SDV 15ML | $1643.64 | FSS | Fresenius Kabi, LLC | 05/14/2030 |
| 63323-0113-10PENTAM 300 SDV 15ML | $492.72 | Big4 | Fresenius Kabi, LLC | 05/14/2030 |
Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.
2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
No patent or exclusivity listings for this strength.